Does CASIRIVIMAB\IMDEVIMAB Cause Lung opacity? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Lung opacity have been filed in association with CASIRIVIMAB\IMDEVIMAB. This represents 0.3% of all adverse event reports for CASIRIVIMAB\IMDEVIMAB.
14
Reports of Lung opacity with CASIRIVIMAB\IMDEVIMAB
0.3%
of all CASIRIVIMAB\IMDEVIMAB reports
0
Deaths
13
Hospitalizations
How Dangerous Is Lung opacity From CASIRIVIMAB\IMDEVIMAB?
Of the 14 reports, 13 (92.9%) required hospitalization.
Is Lung opacity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CASIRIVIMAB\IMDEVIMAB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does CASIRIVIMAB\IMDEVIMAB Cause?
Infusion related reaction (875)
Dyspnoea (687)
Nausea (416)
Oxygen saturation decreased (390)
Dizziness (357)
Pyrexia (306)
Chest discomfort (294)
Chills (265)
Flushing (238)
Cough (235)
What Other Drugs Cause Lung opacity?
ALBUTEROL (296)
PREDNISONE (216)
TIOTROPIUM (196)
LANSOPRAZOLE (166)
IPRATROPIUM (157)
ACETAMINOPHEN (153)
MEPOLIZUMAB (149)
PANTOPRAZOLE (140)
BUDESONIDE\FORMOTEROL (139)
MONTELUKAST (137)
Which CASIRIVIMAB\IMDEVIMAB Alternatives Have Lower Lung opacity Risk?
CASIRIVIMAB\IMDEVIMAB vs CASPOFUNGIN
CASIRIVIMAB\IMDEVIMAB vs CATEQUENTINIB
CASIRIVIMAB\IMDEVIMAB vs CC-4047
CASIRIVIMAB\IMDEVIMAB vs CEDAZURIDINE\DECITABINE
CASIRIVIMAB\IMDEVIMAB vs CEDIRANIB